Pierre Lemire wins MedTECH Executive of the Year from Executive Global magazine.

"The technology we are building is unique and extremely valuable. It’s changing how clinicians treat acute and chronic wounds with critical insights they have never had before."

- Pierre Lemire

Congratulations to Kent Imaging's CEO, Pierre Lemire, on winning 2022’s Medical Technology Executive of the Year, Canada, from Executive Global magazine. This award is based on technological innovation and a sophisticated approach to sustaining life using technology, research and development, industry impact, and a commitment to improving the general health of the wider community under challenging circumstances.

Mr. Lemire is a technology commercialization expert with over 30 years of experience in the high-tech world of imaging. His past roles as CTO at Autodesk Inc., and co-founder of Calgary Scientific, provide key experiences that he uses to guide Kent Imaging’s corporate strategy and global vision. On a local level, he works closely with the Kent team and industry peers to heighten Calgary’s profile as a place where MedTech innovation can thrive.

SnapshotNIR is a near-infrared (NIR), reflectance-based technology that measures tissue oxygen saturation (StO2) in superficial tissue using multiple wavelengths of NIR light. Snapshot provides users with a tissue oxygenation map to support medical decision-making, for tracking and trending oxygenation, and for evaluating tissue viability in wound and surgical care. The cost-effective and easy-to-use wound imaging device is non-invasive, eliminating the need for patient contact or injected dyes while near-instantaneously capturing critical diagnostic insights at the point of care.

"The technology we are building is unique and extremely valuable. It’s changing how clinicians treat acute and chronic wounds with critical insights they have never had before." - Pierre Lemire

It is an honor to have Kent’s leader and the innovative SnapshotNIR recognized on the world stage. Kent Imaging’s mission is to help improve outcomes and reduce complications in as many patients as possible. Visit the website to learn more about how the company is changing the game in advanced tissue assessment.

For all award winners, click here.